Lu Yan, Zhang Qiaohong, Jiang Jinwen
Clinical Laboratory, DongYang People's Hospital, 60 West Wuning Road, Dongyang, 322100, Zhejiang, China.
Sci Rep. 2022 Apr 15;12(1):6316. doi: 10.1038/s41598-022-10438-y.
Risk stratification and prognosis evaluation of severe thrombocytopenia are essential for clinical treatment and management. Currently, there is currently no reliable predictive model to identify patients at high risk of severe thrombocytopenia. This study aimed to develop and validate a prognostic nomogram model to predict in-hospital mortality in patients with severe thrombocytopenia in the intensive care unit. Patients diagnosed with severe thrombocytopenia (N = 1561) in the Medical Information Mart for Intensive Care IV database were randomly divided into training (70%) and validation (30%) cohorts. In the training cohort, univariate and multivariate logistic regression analyses with positive stepwise selection were performed to screen the candidate variables, and variables with p < 0.05 were included in the nomogram model. The nomogram model was compared with traditional severity assessment tools and included the following 13 variables: age, cerebrovascular disease, malignant cancer, oxygen saturation, heart rate, mean arterial pressure, respiration rate, mechanical ventilation, vasopressor, continuous renal replacement therapy, prothrombin time, partial thromboplastin time, and blood urea nitrogen. The nomogram was well-calibrated. According to the area under the receiver operating characteristics, reclassification improvement, and integrated discrimination improvement, the nomogram model performed better than the traditional sequential organ failure assessment (SOFA) score and simplified acute physiology score II (SAPS II). Additionally, according to decision curve analysis, a threshold probability between 0.1 and 0.75 indicated that our constructed nomogram model showed more net benefits than the SOFA score and SAPS II. The nomogram model we established showed superior predictive performance and can assist in the quantitative assessment of the prognostic risk in patients with severe thrombocytopenia.
严重血小板减少症的风险分层和预后评估对于临床治疗和管理至关重要。目前,尚无可靠的预测模型来识别严重血小板减少症的高危患者。本研究旨在开发并验证一种预后列线图模型,以预测重症监护病房中严重血小板减少症患者的院内死亡率。重症监护医学信息数据库IV中诊断为严重血小板减少症(N = 1561)的患者被随机分为训练组(70%)和验证组(30%)。在训练组中,采用正向逐步选择进行单因素和多因素逻辑回归分析以筛选候选变量,p < 0.05的变量被纳入列线图模型。将列线图模型与传统严重程度评估工具进行比较,该模型纳入了以下13个变量:年龄、脑血管疾病、恶性肿瘤、血氧饱和度、心率、平均动脉压、呼吸频率、机械通气、血管活性药物、持续肾脏替代治疗、凝血酶原时间、活化部分凝血活酶时间和血尿素氮。该列线图校准良好。根据受试者工作特征曲线下面积、重新分类改善和综合判别改善情况,列线图模型的表现优于传统的序贯器官衰竭评估(SOFA)评分和简化急性生理学评分II(SAPS II)。此外,根据决策曲线分析,0.1至0.75之间的阈值概率表明,我们构建的列线图模型比SOFA评分和SAPS II显示出更多的净效益。我们建立的列线图模型显示出卓越的预测性能,可协助对严重血小板减少症患者的预后风险进行定量评估。